Date: September 24th, 09:30-13:00
Location: Idorsia, Basel Switzerland
Closed-loop make-test-design platforms: What is happening in Europe?
Developing products of any kind often happens in iterative cycles. For example, small molecule drugs emerge after numerous cycles of “Lead Optimization”: Medicinal chemists synthesize variants of an active molecule, their activities are then measured in bioassays, based on which a new round of syntheses is planned.
The idea to fully automate, and thereby enormously accelerate, such development cycles has been around for many years. However until recently, the technical challenges were simply too high.
With recent advances in the automation of chemistry, biology, and machine learning approaches, this is about to change. An increasing number of companies and institutions are taking on the challenge.
In this interactive meeting, we want to engage in a dialog to address questions such as these:
- Where are closed-loop make-test-design platforms emerging in Europe and beyond?
- What is the status on integral automation of chemistry and bioassays?
- How will such systems be controlled, what is the role of AI/machine learning?
- What is the role of standards such as SiLA to enable such platforms?
The discussion will be launched and guided by experts in chemistry and biology lab automation from Roche, Novartis, Idorsia, and other companies. Seats are limited, we therefore ask for registration by e-mail.
If you are interested to actively contributeto the event, please get in contact with the Organizing Committee directly by e-mail. We look forward to hearing from you.